- Record: found
- Abstract: not found
- Article: not found
Dostarlimab in advanced/recurrent (AR) mismatch repair deficient/microsatellite instability–high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC): The GARNET study.
Ana Oaknin, Bhavana Pothuri, Lucy Gilbert, Renaud Sabatier, SharadA. Ghamande, Adriano Gravina, Emiliano Calvo, SusanaN. Banerjee, Rowan Miller, Joanna Pikiel, MansoorRaza Mirza, Tao Duan, Sybil Zildjian, Eleftherios Zografos, JenniferLynnTaylor Veneris, Anna Tinker, A. Oaknin, B Pothuri, L. GILBERT, R. SABATIER, S Ghamande, A. GRAVINA, E. CALVO, S. Banerjee, R Miller, J Pikiel
2022
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.